2019年2月18日星期一

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

G Bourne, A Bhandari, X Cheng… - US Patent App. 10 …, 2019 - Google Patents
This application is a Divisional of US application Ser. No. 14/800,627, filed Jul. 15, 2015, now
US Pat. No. 9,624,268, issued Apr. 18, 2017; which claims priority to US Provisional Application
No. 62/025,899, filed on Jul. 17, 2014, US Provisional Application No. 62/119,685, filed on …


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论